Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Aphria Inc    APH   CA03765K1049

APHRIA INC (APH)
My previous session
Most popular
  Report  
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
10/05/2018 10/09/2018 10/10/2018 10/11/2018 10/12/2018 Date
16.31 17.42 20.06 19.74 19.11 Last
6099547 10397888 26905693 15543537 11546620 Volume
-0.61% +6.81% +15.15% -1.60% -3.19% Change
Financials (CAD)
Sales 2019 200 M
EBIT 2019 -19,4 M
Net income 2019 29,8 M
Finance 2019 129 M
Yield 2019 -
Sales 2020 576 M
EBIT 2020 33,5 M
Net income 2020 125 M
Finance 2020 213 M
Yield 2020 -
P/E ratio 2019 119,44
P/E ratio 2020 26,54
EV / Sales2019 23,1x
EV / Sales2020 7,87x
Capitalization 4 745 M
More Financials
Company
Aphria, Inc. engages in the production and supply of medical marijuana.Its products include alien dawg, champlian indica, grower's blend, champlain-sativa and blueberry.The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. 
Sector
Pharmaceuticals
Calendar
11/02 | 07:00pmShareholder meeting
More about the company
Surperformance© ratings of Aphria Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on APHRIA INC
10/12Cannabis producer Aphria profit surges on strong demand, investment gains
RE
10/10ALTRIA : Aphria Responds to Media Reports, Says No Deal in Place With Any Invest..
DJ
10/10ALTRIA IN TALKS FOR STAKE IN CANNABI : Globe & Mail
RE
10/09APHRIA INC : quaterly earnings release
08/15Corona owner invests another $4 billion in cannabis producer Canopy
RE
07/27APHRIA INC : annual earnings release
06/21Canada sets October start for legal recreational marijuana sales
RE
02/02APHRIA : Pot company Aphria to sell stake in U.S. cannabis grower
RE
01/03Canadian pot stocks surge on new U.S. fund, California legalization
RE
01/02TSX notches record high as resource shares climb
RE
More news
Sector news : Alternative Medicine
02:02pNovo Nordisk Taps AstraZeneca Executive to Lead Biopharm Unit
DJ
01:34pBAYER : may outsource some drug research - works council
RE
12:34pNovo Nordisk picks AstraZeneca executive to head biopharma business
RE
11:41aConvaTec shares plunge on profit warning and CEO departure
RE
08:15aSHIRE : Rule 2.9 Announcement
DJ
More sector news : Alternative Medicine
News from SeekingAlpha
03/16Did Aurora Overpay For CanniMed? 
03/14Marijuana Stocks And Industry Drivers For 2018 
03/13Marijuana Sales To Start As Soon As August This Year 
03/12WEEKLY CANNABIS REPORT : Ontario And Canopy In The News 
03/08Could Aurora Lower Its Bid For CanniMed Too? 
Chart APHRIA INC
Duration : Period :
Aphria Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
 
Mean consensus BUY
Number of Analysts 7
Average target price 23,1  CAD
Spread / Average Target 21%
EPS Revisions
Managers
NameTitle
Victor Neufeld Chairman, President & Chief Executive Officer
Cole Cacciavillani Director & Vice President-Growing Operations
Carl A. Merton Chief Financial Officer
John Cervini Director & VP-Infrastructure & Technology
Gary Leong Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
APHRIA INC-21.56%3 743
CANOPY GROWTH CORP118.22%10 824
AURORA CANNABIS INC42.81%9 288
BEIJING TONGRENTANG CO., LTD.-8.10%5 874
DONG-E-E-JIAO CO LTD--.--%4 180
HUTCHISON CHINA MEDITECH LIMITED-22.32%3 830